• 1. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 2. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 3. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 4. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 5. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylbutylamines

Professional Introduction to 4-(2-Fluoro-3-methylphenyl)butan-1-amine (CAS No. 1861553-16-3)

4-(2-Fluoro-3-methylphenyl)butan-1-amine is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry due to its unique structural and functional properties. This compound, identified by the CAS number CAS No. 1861553-16-3, represents a promising candidate for further research and development in the synthesis of novel bioactive molecules. The presence of both fluoro and methyl substituents in its aromatic ring system imparts distinct electronic and steric characteristics, making it a valuable scaffold for designing molecules with enhanced binding affinity and selectivity.

The chemical structure of 4-(2-Fluoro-3-methylphenyl)butan-1-amine consists of a butan-1-amine side chain attached to a phenyl ring substituted at the 2-position with a fluorine atom and at the 3-position with a methyl group. This specific arrangement of functional groups contributes to its potential utility in the development of drugs targeting various biological pathways. The fluorine atom, in particular, is known for its ability to modulate metabolic stability and binding interactions, while the methyl group can influence the conformational flexibility of the molecule.

In recent years, there has been a growing interest in the use of fluorinated aromatic compounds in medicinal chemistry due to their favorable pharmacokinetic properties. Studies have demonstrated that fluorine atoms can enhance the lipophilicity and metabolic stability of drug candidates, thereby improving their bioavailability and duration of action. The compound 4-(2-Fluoro-3-methylphenyl)butan-1-amine exemplifies this trend, as its molecular design incorporates these beneficial features.

One of the most compelling aspects of 4-(2-Fluoro-3-methylphenyl)butan-1-amine is its potential application in the synthesis of central nervous system (CNS) drugs. The combination of the fluoro-substituted phenyl ring and the amine side chain creates a molecular framework that can interact with neurotransmitter receptors and transporters. Preliminary computational studies suggest that this compound may exhibit properties similar to those of known CNS-active agents, making it a promising lead for further exploration.

The pharmaceutical industry has increasingly recognized the importance of structurally diverse molecules in drug discovery. The unique combination of substituents in 4-(2-Fluoro-3-methylphenyl)butan-1-amine positions it as a versatile building block for generating novel therapeutic agents. Researchers are exploring its potential use in developing treatments for neurological disorders, where precise modulation of receptor activity is crucial.

Moreover, the synthesis of 4-(2-Fluoro-3-methylphenyl)butan-1-amine presents an interesting challenge for organic chemists due to its complex functionalization requirements. Advanced synthetic methodologies, including cross-coupling reactions and transition-metal catalysis, are being employed to construct the desired molecular architecture efficiently. These efforts not only contribute to the development of new synthetic strategies but also provide valuable insights into the structural features that enhance biological activity.

The use of computational modeling has been instrumental in understanding the pharmacological profile of 4-(2-Fluoro-3-methylphenyl)butan-1-amine. Molecular docking studies have revealed that this compound can bind effectively to various protein targets, including enzymes and receptors relevant to human health. These findings support its potential as a scaffold for designing next-generation therapeutics with improved efficacy and reduced side effects.

In conclusion, 4-(2-Fluoro-3-methylphenyl)butan-1-am ine (CAS No. 1861553-16 -3) represents a significant advancement in pharmaceutical chemistry. Its unique structural features and promising biological activity make it an attractive candidate for further research and development. As our understanding of drug design continues to evolve, compounds like this one will play a crucial role in shaping the future of medicine.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)